These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 6741865)

  • 61. Phase II clinical trial of diaziquone in the treatment of patients with epithelial ovarian cancer: a Gynecologic Oncology Group Study.
    Slayton RE; Blessing JA; Sutton GP; Homesley HD; Park R
    Cancer Treat Rep; 1986 Feb; 70(2):309-10. PubMed ID: 3948196
    [No Abstract]   [Full Text] [Related]  

  • 62. A phase I trial of aziridinylbenzoquinone (NSC 192986) in patients with previously treated acute leukemia.
    Van Echo DA; Schulman P; Budman DR; Ferrari A; Wiernik PH
    Am J Clin Oncol; 1982 Aug; 5(4):405-10. PubMed ID: 7113963
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Phase II evaluation of diaziquone in recurrent head and neck cancer.
    Kish JA; Ensley J; Al-Sarraf M
    Cancer Treat Rep; 1986 May; 70(5):671-2. PubMed ID: 3708616
    [No Abstract]   [Full Text] [Related]  

  • 64. Toxicity of aziridinylbenzoquinone for aerobic and hypoxic cells of a transplanted mouse mammary tumor and interaction of the drug with radiation and adriamycin.
    Tannock I
    Cancer Res; 1983 May; 43(5):2059-62. PubMed ID: 6831436
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Phase II trials of the single agents baker's antifol, diaziquone, and epirubicin in advanced pancreatic cancer. Gastrointestinal Tumor Study Group.
    Cancer Treat Rep; 1987 Sep; 71(9):865-7. PubMed ID: 3476203
    [No Abstract]   [Full Text] [Related]  

  • 66. Phase II study of aziridinylbenzoquinone (AZQ) in patients with central nervous system malignancies: a Southwest Oncology Group Study.
    Taylor SA; McCracken JD; Eyre HJ; O'Bryan RM; Neilan BA
    J Neurooncol; 1985; 3(2):131-5. PubMed ID: 2993536
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Phase II trial of diaziquone in advanced ovarian carcinoma. European Organization for Research on Treatment of Cancer Early Clinical Trials Group.
    Lund B; Bramwell V; Renard J; Hansen HH; Dombernowsky P
    Cancer Treat Rep; 1985 Mar; 69(3):339-40. PubMed ID: 3872170
    [No Abstract]   [Full Text] [Related]  

  • 68. Phase II evaluation of diaziquone in gastric and pancreatic cancers. A Southeastern Cancer Study Group Trial.
    DeSimone P; Kramer B; Omura GA; Bartolucci AA
    Am J Clin Oncol; 1986 Oct; 9(5):401-2. PubMed ID: 3776902
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Phase I evaluation of diaziquone in childhood cancer. A Pediatric Oncology Group study.
    Falletta JM; Cushing B; Lauer S; Bell B; Mahoney DH; Castleberry R; Krance RA
    Invest New Drugs; 1990 May; 8(2):167-70. PubMed ID: 2384303
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Interaction of gamma-irradiation with two new antineoplastic agents, aziridinylbenzoquinone (AZQ) and 4'- (acridinylamino)methanesulfon-m-anisidide (AMSA), in murine tumors in vivo.
    Johnson RK; Wodinsky I; Swiniarski J; Meaney KF; Clement JJ
    Int J Radiat Oncol Biol Phys; 1979 Sep; 5(9):1605-9. PubMed ID: 583418
    [No Abstract]   [Full Text] [Related]  

  • 71. A phase I trial of high-dose diaziquone and autologous bone marrow transplantation: an Illinois Cancer Council study.
    Stiff PJ; McKenzie RS; Potempa LD; Albain K; Koch D; Braud E; Bansal VK; Weidner MK; Lanzotti VJ; Chun HG
    J Clin Oncol; 1991 Aug; 9(8):1487-94. PubMed ID: 2072148
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Anaphylactoid reaction due to AZQ.
    Budman DR; Schulman P; Vinciguerra V; Weiselberg L; Degnan TJ
    Cancer Chemother Pharmacol; 1982; 8(3):317. PubMed ID: 7127664
    [No Abstract]   [Full Text] [Related]  

  • 73. Phase I study of ethylbis(2,2-dimethyl-1-aziridinyl) phosphinate (AB-163).
    Wampler GL; Kuperminc M; Regelson W
    Cancer Chemother Pharmacol; 1980; 4(1):49-52. PubMed ID: 7363402
    [TBL] [Abstract][Full Text] [Related]  

  • 74. A phase II study of diaziquone in children with recurrent or progressive solid tumors. Report from the Childrens Cancer Study Group.
    Ettinger LJ; Ru N; Krailo MD; Ruccione KS; Krivit WA; Hammond GD
    Am J Pediatr Hematol Oncol; 1990; 12(3):301-5. PubMed ID: 2240475
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Phase II study of aziridinylbenzoquinone in refractory lymphoma.
    Case DC; Hayes DM
    Cancer Treat Rep; 1983 Nov; 67(11):993-6. PubMed ID: 6357437
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Aziridinylbenzoquinone (AZQ) treatment of central nervous system leukemia.
    Kamen BA; Holcenberg JS; Siegel SE
    Cancer Treat Rep; 1982 Dec; 66(12):2105-6. PubMed ID: 6958367
    [No Abstract]   [Full Text] [Related]  

  • 77. Phase I/II trial and pharmacokinetics of intrathecal diaziquone in refractory meningeal malignancies.
    Berg SL; Balis FM; Zimm S; Murphy RF; Holcenberg J; Sato J; Reaman G; Steinherz P; Gillespie A; Doherty K
    J Clin Oncol; 1992 Jan; 10(1):143-8. PubMed ID: 1727916
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Diaziquone (AZQ).
    Bender JF; Grillo-Lopez AJ; Posada JG
    Invest New Drugs; 1983; 1(1):71-84. PubMed ID: 6381377
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Superiority of PCNU over AZQ in the treatment of primary brain tumors: results of a prospective randomized trial (81-20) by the Brain Tumor Study Group.
    Malkin MG; Green SB; Byar DP; Strike TA; Burger PC; Vogel FS; Pistenmaa DA; Mahaley MS; Ransohoff J; Shapiro WR
    J Neurooncol; 1994; 22(1):55-65. PubMed ID: 7714551
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Phase II and pharmacokinetic study of aziridinylbenzoquinone [2,5-diaziridinyl-3,6-bis(carboethoxyamino)-1,4-benzoquinone, diaziquone, NSC 182986] in high-grade gliomas.
    Curt GA; Kelley JA; Kufta CV; Smith BH; Kornblith PL; Young RC; Collins JM
    Cancer Res; 1983 Dec; 43(12 Pt 1):6102-5. PubMed ID: 6640549
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.